Publicacións en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (21)

2023

  1. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87

  2. Effects of MIdazolam versus MOrphine in acute cardiogenic pulmonary edema and chronic obstructive pulmonary disease: An analysis of MIMO trial

    American Journal of Emergency Medicine, Vol. 73, pp. 176-181

  3. Effects of midazolam vs morphine in patients with acute pulmonary edema with left ventricular systolic dysfunction: a secondary analysis of data from the MIMO trial

    Emergencias, Vol. 35, Núm. 1, pp. 25-30

  4. Midazolam versus morphine in acute cardiogenic pulmonary edema patients with and without atrial fibrillation: findings from the MIMO trial

    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, Vol. 30, Núm. 2, pp. 78-84

2022

  1. Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1953-1962

  2. Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study

    European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891

2021

  1. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  2. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries

    Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182

2020

  1. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

    American Heart Journal, Vol. 220, pp. 108-115

  2. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

    International Journal of Cardiology, Vol. 301, pp. 200-206

  3. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries

    American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269

  4. Identification of Senior At Risk scale predicts 30-day mortality among older patients with acute heart failure

    Medicina Intensiva, Vol. 44, Núm. 1, pp. 9-17

  5. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry

    European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705

  6. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

2019

  1. Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 6, pp. 536-542

2018

  1. Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry

    International Journal of Cardiology, Vol. 273, pp. 29-33

2017

  1. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial

    Journal of Pineal Research, Vol. 62, Núm. 1

  2. Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)

    American Journal of Cardiology, Vol. 120, Núm. 4, pp. 522-526

2016

  1. Thrombus aspirated from patients with ST-elevation myocardial infarction: Association between 3-nitrotyrosine and inflammatory markers – Insights from ARTERIA study

    International Journal of Medical Sciences, Vol. 13, Núm. 7, pp. 477-482

2010

  1. Letter by dominguez-rodriguez et al regarding article, "c-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation"

    Circulation